Clinical trial
Dexamethasone With or Without Thalidomide in Treating Patients With Newly…
NCT00033332 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00033332 |
|---|---|
| Title | Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma |
| Official title | A Randomized Phase III Trial Of Thalidomide (NSC # 66847) Plus Dexamethasone Versus Dexamethasone In Newly Diagnosed Multiple Myeloma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug |
| Interventions | dexamethasone, pamidronate disodium, thalidomide, zoledronic acid |
| Start date | Apr 1, 2002 |
| Primary completion | Mar 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 4, 2014 |
| Countries | Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: